VEGFA and age-related macular degeneration: We previously reported that in patients with AMD who had final BCVA ≤ 0.3 logMAR or improvements of > 15 letters after anti-VEGF therapy exhibited greater improvements in National Eye Institute Visual Function Questionnaire-25 composite score, compared with patients who did not experience BCVA improvements; this finding suggested that better final BCVA was important for vision quality, regardless of the method to achieve improved BCVA [12].